高盛研究报告指,京东健康(06618.HK) 今年首季收入和利润均超出预期,主要受强劲的药品和营养产品势头、以及毛利率扩张推动。该行重申对京东健康在行业领先地位的信心,因为公司拥有强大的供应链能力和品牌认知度。管理层目前预计今年全年收入增长双位数,营业利润按年大致持平。该行认为指引相对保守,因考虑到今年下半年有较多投资,亦相信集团将扩大其市场份额,尤其是在药品类别,并会受惠于对自订派送的增长。该行...
Source Link高盛研究报告指,京东健康(06618.HK) 今年首季收入和利润均超出预期,主要受强劲的药品和营养产品势头、以及毛利率扩张推动。该行重申对京东健康在行业领先地位的信心,因为公司拥有强大的供应链能力和品牌认知度。管理层目前预计今年全年收入增长双位数,营业利润按年大致持平。该行认为指引相对保守,因考虑到今年下半年有较多投资,亦相信集团将扩大其市场份额,尤其是在药品类别,并会受惠于对自订派送的增长。该行...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.